Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases:hypertrophic cardiomyopathy, long-QT syndrome, and Marfan syndrome. A statement for healthcare professionals from the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association.
Maron
B J
BJ
Moller
J H
JH
Seidman
C E
CE
Vincent
G M
GM
Dietz
H C
HC
Moss
A J
AJ
Sondheimer
H M
HM
Pyeritz
R E
RE
McGee
G
G
Epstein
A E
AE
D000293:Adolescent; D000328:Adult; D000368:Aged; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D002874:Chromosome Mapping; D004992:Ethics, Medical; D018740:Genetic Heterogeneity; D005820:Genetic Testing; D005838:Genotype; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008133:Long QT Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics; D008382:Marfan Syndrome / Q000175:diagnosis* / Q000453:epidemiology / Q000235:genetics; D008875:Middle Aged; D009124:Muscle Proteins / Q000235:genetics; D010641:Phenotype
D009124:Muscle Proteins